Korea / Special Sits, Pairs, Index Rebalancing, Clepsydra Capital

Sanghyun Park

Korea / Special Sits, Pairs, Index Rebalancing

Thematic (Sector/Industry)

<p>SillaJen Biotherapeutics (established in 2006) is indeed a rare breed in Korean pharmaceutical world. It is not a generic drug maker. It is not a biosimilar maker either. It makes new biomedical products. A majority of Korea's pharmaceutical makers are still generic drug makers. The likes of Celltrion and Samsung Bioepis have emerged as a biosimilar maker. But they are still a few. Biomedical makers are even rarer. Hanmi Pharmaceutical is one of these rare breeds. Now, another biomedical maker…</p>

SillaJen Biotherapeutics (established in 2006) is indeed a rare breed in Korean pharmaceutical world. It is not a generic drug maker. It is not a biosimilar maker either. It makes new biomedical products. A majority of Korea's pharmaceutical makers are still generic drug makers. The likes of Celltrion and Samsung Bioepis have emerged as a biosimilar maker. But they are still a few. Biomedical makers are even rarer. Hanmi Pharmaceutical is one of these rare breeds. Now, another biomedical maker…

SillaJen's December IPO: Valuation, Growth Expectation and IPO Timing

South Korea

Samsung Pharmaceutical Co., Ltd. manufactures medicines to treat a variety of diseases.  The Company's products include medicines for inflammatory, nutrition, and digestive system.

Daehan New Pharm Co., Ltd. develops, manufactures, and markets pharmaceutical drugs, such as vaccines, diagnostic kits, and antibiotics.  The Company also produces various veterinary drugs and baby cares.  Daehan New Pharm exports its products to Japan, Malaysia, Vietnam, and Brazil.

Daihan Pharmaceutical Co., Ltd. manufactures and markets pharmaceutical products, such as parenterals, commonly known as intravenous (IV) fluids. The Company also produces other pharmaceutical products, including injectables, antibiotics, nutritional supplements, and anesthetics.  Daihan supplies its products to hospitals and private pharmacies through its own sales network.

Ilsung Pharmaceuticals Co., Ltd. manufactures pharmaceuticals, such as antibiotics, analgesics, inhalation anesthetics and multi-vitamins. The Company sells its products to local hospitals.

Enzychem Lifesciences Corporation manufactures and distributes drugs. The Company manufactures active pharmaceutical ingredients, pharmaceutical intermediates, and cosmetic ingredients. Enzychem Lifesciences also produces functional health foods and finished drug products.

High Tech Pharm Co Ltd. manufactures sterile and oral antibiotics.  The Company's products include sterile bulk forms of Cephalosporine and Carbapenem related antibiotics.  High Tech Pharm also exports active pharmaceutical ingredients.

Hwail Pharm Co., Ltd. produces pharmaceutical raw materials.  The Company's products include Talniflumate, Alibendol, and Oxatomide.  Hwail supplies these materials to companies dealing with finished pharmaceutical products.

Dongsung Pharmaceutical Co., Ltd. manufactures pharmaceutical products, such as antibiotics and dermatological medicines. The Company also produces and markets cosmetic products.

Kukje Pharma Ind. Co., Ltd. manufactures medical drugs.  The Company's products include antibiotics, vitamins, nutritional agents, and other drugs for supply to hospitals.  Kukje Pharma Ind. also sells apartments.

Kyungdong Pharm. Co., Ltd. manufactures prescription drugs including antibiotics and analgesics.  The Company sells its products to hospitals and pharmacies. Kyungdong Pharm. provides its products to domestic and overseas markets.

PT Merck Tbk manufactures pharmaceutical products. The Company also distributes pharmaceutical raw materials, chemicals reagents, and medical instruments.

Hangzhou Tian-Mu-Shan Pharmaceutical Enterprise Co., Ltd. researches, manufactures, and markets traditional Chinese medicines, western medicines, and biomedicines.  The Company also manufactures printed circuit boards and paper products.

Hangzhou Tian Mu Shan Pharm. Enterp. Co (600671 CH)

Chunghwa Chemical Synthesis & Biotech Co Ltd is a biomedical company. The Company contract manufactures a wide range of pharmaceutical products, including pain management, antifungal, immunosuppressant, as well as provides synthesis and biotechnology technologies.

Chunghwa Chemical Synthesis & Biotech (1762 TT)

Ind-Swift Laboratories Ltd. manufactures bulk drugs and intermediates.  The Company's product portfolio includes anti-infective, anti-allergy, analgesic and cardiovascular medicines.

Johnson Chemical Pharmaceutical Works Corp. develops medical and biotechnology products.

Jagsonpal Pharmaceuticals  develops and  manufactures bulk drugs and pharmaceutical formulations.

RaQualia Pharma, Inc. is a pharmaceutical company. The Company develops compounds for patient studies and sells drugs to pharmaceutical manufacturers. RaQualia also provides research on remedies in gastrointestinal, liver diseases, and pain in general areas.

Symbio Pharmaceuticals Limited develops and commercializes prescription drugs n oncology, hematology and auto-immune disease for Japan and other Asia Pacific markets.

Lansen Pharmaceutical holdings Ltd. is a pharmaceutical holding company. The Company's subsidiaries produce and sell rheumatic specialty prescription western pharmaceuticals in the Peoples Republic of China.

Lansen Pharmaceutical Holdings Co, Ltd. (503 HK)

Darya-Varia Laboratoria Tbk PT manufactures, trades, and distributes pharmaceuticals and related chemicals, as well as health care products.

Jeil Pharma Holdings Inc. operates as a pharmaceutical manufacturing company. The Company manufactures analgesic anti-inflammatories, broad-spectrum oral antimicrobial agents, analgesic anti-cold poultice poultices, hyperlipidemia agents, intravenous antibiotics, and other products. Jeil Pharma Holdings markets its products throughout Korea.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Jeil Pharma Holdings (002620 KS)

SillaJen's December IPO: Valuation, Growth Expectation and IPO Timing

SillaJen Biotherapeutics (established in 2006) is indeed a rare breed in Korean pharmaceutical world. It is not a generic drug maker. It is not a...

Sanghyun Park

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)